Ocean Biomedical receives noncompliance notification from Nasdaq

Ocean Biomedical announced that it received a notice from Nasdaq stating that because the company has not yet filed its quarterly report on Form 10-Q for the period ended June 30, the company is not in compliance with Nasdaq Listing Rule 5250, which requires listed companies to timely file all required periodic reports with the SEC.